Streetbeat News

Stock Prices

MSFT

Microsoft Corp (NASDAQ:MSFT) is internally debating adding new Call of Duty titles to Xbox Game Pass following its acquisition of Activision Blizzard. Concerns include potential revenue loss for the franchise and a price hike for the Game Pass Ultimate tier. Microsoft faces challenges with declining Game Pass subscriptions, slow console sales, and game release delays. Despite these issues, the Call of Duty franchise remains highly profitable, with significant sales on both Xbox and PlayStation platforms. Microsoft also recently closed four Bethesda Studios, indicating possible future cutbacks in its gaming division.

Portfolio Pulse from Franca Quarneti

May 09, 2024 | 6:22 pm

NU

Investors have shown a mixed sentiment towards Nu Holdings (NYSE:NU), with options trading indicating a bearish stance overall. Benzinga's options scanner revealed 9 significant trades, with a split sentiment of 33% bullish and 55% bearish. The trades suggest a price band focus between $9.0 and $20.0 for NU. The company, specializing in digital banking services, has seen its stock price decrease by 0.42% to $11.95, with an RSI indicating a potential overbought situation. Analysts, including one from Keybanc, maintain an Overweight rating with a target price of $13.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:16 pm

BX

KKR

Shares of Blackstone Inc. (NYSE:BX) and KKR & Co. Inc. (NYSE:KKR) are trading higher as Sony Music Entertainment is reported to compete with them to acquire Infocom Corp., a Japanese e-comics provider, in a deal worth about $1.3 billion. The booming e-comics market and the strategic interests of these firms in digital content are highlighted by their involvement in this potential acquisition.

Portfolio Pulse from Nabaparna Bhattacharya

May 09, 2024 | 6:06 pm

FDX

Market whales have shown a mixed but notably bullish interest in FedEx (NYSE:FDX) options, with trades indicating a focus on a price range between $200.0 and $300.0. Analysis of options trading volume and open interest for FedEx reveals significant activity, with a balance between bullish and bearish sentiments among investors. FedEx's stock price has recently increased by 1.13%, with an RSI suggesting it may be approaching oversold territory. The company, a leader in express package delivery, continues to derive the majority of its revenue from its express, ground, and freight divisions.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:02 pm

NRDY

In the last three months, Nerdy (NYSE:NRDY) received mixed analyst ratings, with a shift towards a more positive outlook in recent evaluations. The average 12-month price target for NRDY has been raised to $4.19 from $3.25, indicating a 28.92% increase. Analysts from Goldman Sachs, Needham, and JP Morgan have updated their ratings and price targets, reflecting changes in market conditions and Nerdy's performance. Despite a lower market capitalization and challenges in profitability, Nerdy has shown impressive revenue growth of 31.77% as of December 31, 2023, surpassing industry averages in the Consumer Discretionary sector.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:01 pm

CXW

Recent analyst ratings for CoreCivic (NYSE:CXW) show a unanimous somewhat bullish outlook, with four analysts maintaining an 'Outperform' rating. The 12-month price target has been raised to an average of $18.75, indicating a 7.14% increase from the previous target of $17.50. CoreCivic's financial performance shows a revenue growth of 4.2% for the last quarter of 2023, but it trails behind industry averages in net margin, ROE, and ROA, indicating potential challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:00 pm

GXO

GXO Logistics (NYSE:GXO) has been the subject of 7 analyst ratings over the past three months, showing a mix of bullish to bearish sentiments. The average 12-month price target has been adjusted to $70.00, a decrease from the previous $73.33. Analyst actions include both upgrades and downgrades, with price targets ranging from $50.00 to $82.00. GXO's financial performance is strong, with revenue growth, net margin, ROE, and ROA all surpassing industry benchmarks. The company's market capitalization is below industry standards, but it maintains a balanced debt approach.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:00 pm

ACVA

ACV Auctions (NASDAQ:ACVA) has been evaluated by 5 analysts over the last three months, showing a mix of bullish to bearish sentiments. The average 12-month price target for ACVA is $20.8, with a high of $23.00 and a low of $16.00, indicating a 2.31% increase from the previous target of $20.33. The company's financials reveal a positive revenue growth rate of 20.83% as of December 31, 2023, but a net margin of -19.63% and an ROA of -2.47%, suggesting challenges in profitability and asset utilization. Despite this, ACV Auctions has a strong ROE of -5.03% and a conservative debt-to-equity ratio of 0.25.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 6:00 pm

NOVC

SNDL

SNDL Inc. reported a Q1 2024 net revenue of CA$197.7 million, up from the previous year, with a gross profit of CA$50.4 million and a reduced net loss of CA$4.6 million. The company has no outstanding debt and is expanding in the US through a joint venture. SNDL and Nova Cannabis Inc. completed a deal transferring rights of four Dutch Love stores to Nova, with SNDL receiving $8.179 million in Nova shares.

Portfolio Pulse from Jelena Martinovic

May 09, 2024 | 6:00 pm

CPOP

DUOL

EMKR

SEZL

SGD

TIVC

Duolingo shares fell by 18% after reporting Q1 financial results, despite beating analyst estimates for earnings and sales. The company's Q2 and full-year revenue forecasts were slightly below estimates. Other stocks showed significant movement, with notable gainers including Pop Culture Group, Sezzle Inc., and Safe and Green Development, among others. Losers included Tivic Health Systems, EMCORE Corporation, and CytomX Therapeutics, with various reasons such as public offerings, mixed financial results, and clinical study data.

Portfolio Pulse from Avi Kapoor

May 09, 2024 | 5:57 pm